Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study.

Onco Targets Ther · 2017 · PMC5546817 · PMID 28814884

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

approximately significantP =0.05actually significant

Only pre-EBV DNA showed an approximately significant difference in 4-year DMFS (HR =1.05; 95% CI =0.38–0.83; P =0.05).

also in 60 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.